APOE and supranuclear palsy, progressive, 1: In our current study, we found an increased risk of PSP (and CBD, though not reaching statistical significance) in patients with the recessive APOE ε2/ε2 genotype, which given the rarity of this genotype may explain why it was not detected in the previous genome-wide association study (GWAS) of PSP41.